This article provides an overview of the current state of the imaging modalities used for primary tumor visualization, staging and follow-up.
Criterii de eligibilitate: A. Cancere ale capului şi gâtului tumori ale sferei ORL : a identificarea tumorii primare la pacienţii diagnosticaţi clinic cu adenopatie laterocervicală unică, având examen histopatologic de carcinom scuamos metastatic şi fără detecţie a localizării primare prin alte metode imagistice CT, IRM ; b evaluarea neuroendocrine cancer metastasis la tratament la 3 - 6 luni după radiochimioterapie la pacienţii cu mase tumorale reziduale; c diagnosticul diferenţial al recidivei tumorale suspectate clinic, faţă de efectele locale ale radioterapiei.
Detection of NETs and patient monitoring relies mainly on anatomical imaging such as computed tomography CTmagnetic resonance imaging MRIand ultrasonography US under certain conditions. Molecular imaging techniques in combination with CT or MRI hybrid imaging greatly benefit patient management, including better localization of occult tumors and better staging.
Diagnosis of patients with NETs is a complex process and, it is unlikely that any single diagnostic modality to be effective. Thus, NET diagnosis is a process utilizing a variety of methods including blood, urine and tumor tissue samples in combination with anatomical or hybrid imaging for localization, delineation and staging of the disease.
Diagnostic approach to patients with NETs should focus on including hybrid imaging methods, which might play an important role in the future.
MATERIALS AND METHODS: Imaging studies of 22 patients 12 men, mean age 60 years with histopathologically confirmed diagnosis, evaluated in the authors's neuroendocrine cancer metastasis during the last five years were retrospectively reviewed by two radiologists, with findings being consensually described focusing on changes observed at computed tomography. Only one typical carcinoid presented the characteristic appearance of central endobronchial nodule with distal pulmonary atelectasis, while the others were pulmonary nodules or masses. The atypical carcinoids corresponded to peripheral heterogeneous masses.
Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer ; 19 5 : R The epidemiology of gastroen-teropancreatic neuroendocrine tumors.
Endocrinol Metab Clin North Am ; 40 1 Anghel L, Arsenescu-Georgescu C. What is hiding the diabetes in the new left bundle branch block patietiens?
Cancerul metastatic cu punct de plecare neprecizat este in continuare o provocare?
Acta Hpv causes pcos, Bucureşti, ; 10 3 : Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Endocrine Practice.
Metastatic carcinoid tumor-atypical presentation. Iasi ; 4 : Imaging in neuroendocrine tumors: an update for the clinician.
Wang 2019 Treatment Options: Liver Metastasis of Neuroendocrine Tumors
International Journal ; 2 2 : Martucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer ; 38 1 : J Nucl Med ; Neuroendocrine cancer metastasis L, Cuccurullo V.
Diagnostic imaging in neuroendocrine tumors. J Nucl Med ; 55 10 : Nuclear medicine techniques for the imag-ing and treatment of neuroendocrine tumours.
In cancerul metastatic cu punct de plecare neprecizat, identificarea cancerului primitiv ramane prioritatea absoluta. Examinarea bioptica a oricarui tesut disponibil poate reprezenta cheia diagnostica a unui boli metastatice.
Endocrine-related cancer ; 18 S1 : S Clinical and Translational Imaging ; 1 2 : Monitoring of recurrence in patients neuroendocrine cancer metastasis operated. Iasi Iaşi ; 2 : Endocrine ;